MICROVASCULAR ANASTOMOTIC DEVICE
K040163 · Synovis Micro Companies Alliance, Inc. · MVR · Apr 16, 2004 · General, Plastic Surgery
Device Facts
| Record ID | K040163 |
| Device Name | MICROVASCULAR ANASTOMOTIC DEVICE |
| Applicant | Synovis Micro Companies Alliance, Inc. |
| Product Code | MVR · General, Plastic Surgery |
| Decision Date | Apr 16, 2004 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 878.4300 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The Microvascular Anastomotic COUPLER is to be used in the anastomosis of veins and arteries normally encountered in microsurgical and vascular reconstructive procedures.
Device Story
Microvascular Anastomotic Coupler is a sterile, single-use implantable device; consists of a pair of high-density polyethylene rings, each featuring six stainless steel pins. Designed for use in microsurgical and vascular reconstructive procedures to facilitate vein and artery anastomosis. Includes a molded probe-holder feature on the rings to allow attachment of a sensor/probe at the anastomosis site. Used by surgeons in clinical settings. Provides mechanical support for vessel connection; intended to improve surgical efficiency and patient outcomes in microvascular procedures.
Clinical Evidence
No clinical data provided; substantial equivalence is based on technological characteristics and bench testing comparisons to the predicate device.
Technological Characteristics
Implantable pair of rings; material: high-density polyethylene; pins: stainless steel; sensing/actuation: includes molded probe-holder for sensor/probe attachment; sterilization: gamma irradiation; form factor: single-use, ring-based coupler.
Indications for Use
Indicated for use in the anastomosis of veins and arteries in microsurgical and vascular reconstructive procedures.
Regulatory Classification
Identification
An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable.
Predicate Devices
- GEM Microvascular Anastomotic COUPLER (K861985)
Related Devices
- K090679 — VESSELINK MICROVASCULAR ANASTOMOTIC COUPLER SYSTEM · Vioptix, Inc. · Apr 17, 2009
- K982278 — MICRINS MICRO ANASTOMOSIS CLAMP · Micrins Surgical, Inc. · Mar 26, 1999
- K970793 — IMPLANTABLE CLIP · United States Surgical, A Division of Tyco Healthc · Jul 30, 1997
- K090872 — MODIFICATION TO CARDICA C-PORT XA DISTAL ANASTOMOSIS SYSTEM · Cardica, Inc. · Apr 21, 2009
- K073123 — CARDICA C-PORT FLEX-A DISTAL ANASTOMOSIS SYSTEM, MODEL FG-000150 · Cardica, Inc. · Dec 6, 2007
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes representing the department's mission. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
## MAY 1 1 2004
Ms. Daisy P. Sin, MT Synovis Surgical Innovations 2575 university Avenue W. St. Paul., Minnesota 55114
Re: K040163
Trade/Device Name: Microvascular Anastomotic Coupler Regulatory Class: unclassified Product Code: MVR Dated: January 23, 2004 Received: January 26, 2004
Dear Ms. Sin:
This letter corrects our substantially equivalent letter of April 7, 2004 regarding the Indications for Use of your device.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part
{1}------------------------------------------------
Page 2 - Ms. Daisy P. Sin, MT
807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
> [ • Cella M. witten, rn.U., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
K040163 510(k) Number (if known):
Device Name: Microvascular Anastomotic COUPLER
Indications for Use:
The Microvascular Anastomotic COUPLER is to be used in the anastomosis of veins and arteries normally encountered in microsurgical and vascular reconstructive procedures.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Miriam C. Provost
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number K040163
{3}------------------------------------------------
APR 1 6 2004
Synovis™ Micro Companies Alliance, Inc. Microvascular Anastomotic COUPLER
K040163
## 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
| Submitted by: | Synovis™ Micro Companies Alliance, Inc.<br>A Subsidiary of Synovis Life Technologies, Inc.<br>439 Industrial Lane<br>Birmingham, AL 35211-4464 USA<br>FDA Registration #: 1062741 |
|---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Date Prepared: | April 6, 2004 |
| Contact Person: | Daisy P. Sin, MT (ASCP), RAC (RAPS)<br>Synovis Surgical Innovations,<br>A Division of Synovis Life Technologies, Inc.<br>2575 University Ave. W.<br>St. Paul, MN 55114<br>651-796-7399, 651-603-5203 or 1-800-225-4018<br>651-796-7499 (Fax) or 651-603-5211 (Fax) |
| Device Trade Name: | To be determined |
| Common Name: | Microvascular Anstomotic Coupler |
| Predicate Device: | GEM Microvascular Anastomotic COUPLER; K861985<br>Image: signature |
| Device Description: | The device is a sterile (gamma irradiation), single-use,<br>implantable pair of rings molded out of high density<br>polyethylene with six stainless steel pins on each of the<br>ring. A probe-holder feature is molded on each of the<br>paired rings to be a point of attachment for a<br>sensor/probe at the site of anastomosis. |
| Indications for Use: | The device is for use in the anastomosis of veins and<br>arteries normally encountered in microsurgical<br>procedures. |
| Technological Comparison: | The proposed device has the same technological<br>characteristics as the predicate device. |
| Summary: | The device is substantially equivalent to the predicate<br>device with respect to biocompatibility, manufacturing<br>process, product performance, sterilization, shelf life,<br>packaging, and safety and efficacy. |